Mechanisms of Tumor-Associated Edema: A Review
Open Access
- 1 May 1990
- journal article
- review article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences
- Vol. 17 (2) , 177-183
- https://doi.org/10.1017/s0317167100030419
Abstract
An understanding of the mechanisms responsible for tumor-associated edema involves the elucidation of the role played by a number of intra-related processes. These include (i) the permeability of new tumor microvessels that are associated with tumor angiogenesis; (ii) alterations in microvascular permeability due to factors secreted by tumor cells; (iii) immunological mechanisms and (iv) increased microvessel permeability associated with inflammation. The rationale for a role for inflammatory processes in tumor-associated edema has been outlined and the role of non-steroidal anti-inflammatory drugs in modulating experimental and human tumor-associated edema has been explored.Keywords
This publication has 53 references indexed in Scilit:
- Protective effect of a 21-aminosteroid on the blood-brain barrier following subarachnoid hemorrhage in rats.Stroke, 1989
- Dexamethasone Therapy for Bacterial MeningitisNew England Journal of Medicine, 1988
- 21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils.Stroke, 1988
- Effect of ibuprofen on tumor growth in the C6 spheroid implantation glioma modelJournal of Neurosurgery, 1988
- Attenuation of postischemic cerebral hypoperfusion by the 21-aminosteroid U74006F.Stroke, 1988
- Quantitative study of microvessel ultrastructure in human peritumoral brain tissueJournal of Neurosurgery, 1987
- Effects of Dexamethasone in Primary Supratentorial Intracerebral HemorrhageNew England Journal of Medicine, 1987
- Cerebral edema associated with meningiomasSurgical Neurology, 1987
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985
- Prostaglandin production by neuroblastoma, glioma and fibroblast cell lines; Stimulation by N6, O2′‐dibutyryl adenosine 3′:5′‐cyclic monophosphateFEBS Letters, 1973